• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Postural Orthostatic Tachycardia Syndrome

Postural Orthostatic Tachycardia Syndrome - 24 Studies Found

Not yet recruiting : Vagal Stimulation in POTS
: Postural Tachycardia Syndrome
: 2017-04-18
:
  • Drug: placebo sugar pill place

NOT_YET_RECRUITING : Using Mirabegron to Increase BP in Patients With POTS
: Postural Orthostatic Tachycardia Syndrome
: 2025-08-03
: 10 patients will receive drug for 8 weeks
Completed : Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS
: Post-COVID Postural Orthostatic Tachycardia Syndrome Postural Orthostatic Tachycardia Syndrome
: 2025-08-03
: Participants will receive efgartigimod IV 10 mg/kg open label, respectively.
COMPLETED : A MHealth System for Patients with POTS
: POTS - Postural Orthostatic Tachycardia Syndrome
: 2025-08-03
: Participants will be asked to document symptoms daily in the mHealth app and will be asked to conduct an "at home stand test" biweekly throu
<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.